Article
Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency.
Journal of the neurological sciences - 15 Apr 2014
Lehmann Diana, Zierz Stephan
Abstract excerpt
The biochemical consequences of the disease causing mutations of muscle carnitine palmitoyltransferase II (CPT II) deficiency are still enigmatic. Therefore, CPT II was characterized in muscle biopsies of nine patients with genetically proven muscle CPT II deficiency. Total CPT activity (CPT I+CPT II) of patients was not significantly different from that of controls. Remaining activities upon inhibition by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
